MedTrace Logo

A Trial of Wellbutrin for Crohn's Disease

NCT00126373 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2012-01-20

No results posted yet for this study

Summary

The investigators are testing the hypothesis that Wellbutrin (bupropion) can give a clinical remission in Crohn's disease.

Conditions

  • Crohn Disease

Interventions

DRUG

Wellbutrin (bupropion)

bupropion 150mg-300mg daily

Sponsors & Collaborators

Principal Investigators

  • Eric L Altschuler, M.D., Ph.D. · Mt. Sinai Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2006-03-31
Completion
2006-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00126373 on ClinicalTrials.gov